Background Few studies have analyzed the incidence and the risk of acute myocardial
infarction (AMI) during the post-acute phase of COVID-19 infection. Objective To assess the …

Abstract Purpose of Review The risk of cardiovascular complications due to SARS-CoV-2
are significantly increased within the first 6 months of the infection. Patients with COVID-19 …

Background There are a growing number of case reports of various autoimmune diseases
occurring after COVID-19, yet there is no large-scale population-based evidence to support …

Background Few studies have reported the long-term health effects of COVID-19. The
regional population-based Linköping COVID-19 study (LinCoS) included all patients …

Background While cardiovascular disease (CVD) is a risk factor for severe COVID-19, the
association between predicted cardiovascular risk and severe COVID-19 among people …

Data regarding the occurrence of venous thromboembolic events (VTE), including acute
pulmonary embolism (PE) and deep vein thrombosis (DVT) in recovered COVID-19 patients …

Patients recovered from COVID-19 have an increased incidence of cardiovascular disease
and heart structural changes. The aim of the present manuscript is to assess the risk of …

Background Growing evidence suggests that some coronavirus disease 2019 (COVID-19)
survivors experience a wide range of long-term postacute sequelae. We examined the …

The current epidemic of corona virus disease (COVID-19) has resulted in an immense
health burden that became the third leading cause of death and potentially contributed to a …

Introduction Cardiovascular disease (CVD) mortality increased during the initial years of the
COVID-19 pandemic, but whether these trends endured in 2022 is unknown. This analysis …